Expansion Drive Lupin Diagnostics is aggressively expanding its footprint across India with plans to add 300 collection centres in South India and 50 in Tamil Nadu by FY2025, signaling strong growth opportunities for regional labs, logistics partners, and last-mile healthcare services.

NABL CAP Focus With 30% NABL accredited labs and adherence to NABL and CAP guidelines, there is a clear emphasis on quality assurance that can be leveraged to pursue partnerships with higher-tier healthcare providers, hospitals, and clinics seeking compliant, reliable lab services.

End-to-End Logistics Temperature controlled logistics and a large phlebotomy workforce enable scalable home collection and specimen transport, offering sales potential for cold-chain solutions, courier partnerships, and tech-enabled logistics platforms.

Tech Enabled Use of Google Ads, iCIMS, QlikView, AWS, Azure and WhatsApp Business indicates a modern tech stack; opportunities exist to upsell integrated digital platforms, CRM enhancements, and data analytics services to optimize operations and patient engagement.

Revenue Growth Opportunity Current revenue is in the 1–10 million range with rapid geographic expansion; target collaborations with regional hospitals, diagnostic distributors, and corporate health programs to accelerate revenue growth and scale testing volumes.